LncRNA DNAH17-AS1 promotes gastric cancer proliferation and radioresistance by sponging miR-202-3p to upregulate ONECUT2
Discover Oncology · 12.09.2024 · 15 (1)
DOI: 10.1007/s12672-024-01297-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 12.09.2024. Verfasst von Yugang Ge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Jiangyin Clinical College of Xuzhou Medical University, Wuxi, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Youth Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Long noncoding RNAs (lncRNAs) are frequently dysregulated in malignancies and serve as significant regulators of tumorigenesis. The role of the lncRNA DNAH17-AS1 in gastric cancer (GC) remains incompletely understood. In this study, we explored the biological function and underlying mechanism of DNAH17-AS1 in GC. Differences in DNAH17-AS1 expression between GC and normal tissues were evaluated via The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and qRT-PCR validation. CCK-8, colony formation, animal, and flow cytometry assays were performed to detect the effects of DNAH17-AS1 on GC cell proliferation. Further biological experiments combined with bioinformatics analyses were performed to reveal the molecular mechanism involved. The results indicated that DNAH17-AS1 was strongly overexpressed in GC tissues and cells and that high expression of DNAH17-AS1 was correlated with lager tumour size, poor differentiation, and shorter survival. Silencing DNAH17-AS1 inhibited proliferation, induced G1 arrest and apoptosis in GC cells in vitro, and repressed tumorigenesis in vivo. Mechanistically, DNAH17-AS1 acted as a competitive endogenous RNA (ceRNA) for the tumour suppressor miR-202-3p and consequently prevented the degradation of ONECUT2. In addition, the DNAH17-AS1/miR-202-3p/ONECUT2 axis promoted the radioresistance of GC. In summary, DNAH17-AS1 plays crucial roles in GC progression and may be a novel promising target for therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Jiangyin Clinical College of Xuzhou Medical University, Wuxi, China.
- Department of Gastroenterology, Jiangyin Clinical College of Xuzhou Medical University, Wuxi, China.
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Wuxi Key Laboratory of Biomaterials for Clinical Application, Department of Central Laboratory, Jiangyin Clinical College of Xuzhou Medical University, Wuxi, China.
- Department of Oncology, First People's Hospital of Yancheng, Fourth Affiliated Hospital of Nantong University, Yancheng, China.
- Department of General Surgery, Jiangyin Clinical College of Xuzhou Medical University, Wuxi, China. jyqingshao@sina.com.
Förderung
- the Youth Fund of the National Natural Science Foundation of China
Zitieren
APA
Ge, Y., Cang, H., Xiao, J., Wu, H., Wang, B., & Shao, Q. (2024). LncRNA DNAH17-AS1 promotes gastric cancer proliferation and radioresistance by sponging miR-202-3p to upregulate ONECUT2. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01297-2
Vancouver
Ge Y, Cang H, Xiao J, Wu H, Wang B, Shao Q. LncRNA DNAH17-AS1 promotes gastric cancer proliferation and radioresistance by sponging miR-202-3p to upregulate ONECUT2. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01297-2
BibTeX
@article{Ge2024,
author = {Ge, Yugang and Cang, Hui and Xiao, Jian and Wu, Hongshuai and Wang, Biao and Shao, Qing},
title = {LncRNA DNAH17-AS1 promotes gastric cancer proliferation and radioresistance by sponging miR-202-3p to upregulate ONECUT2},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01297-2}
}
EUVIMED